[
  {
    "headline": "shareholder pleased quality revvity nyse rvty earning",
    "text": "revvity inc nyse rvty report healthy earning move much probably"
  },
  {
    "headline": "repligen bruker agilent medpace revvity skyrocket need know",
    "text": "number jump afternoon session major pop nasdaq 3.4 p 500 2.5 response positive outcome u.s.-china trade negotiation side agree pause tariff 90 day signal potential turning point ongoing tension rollback cut u.s tariff chinese good 30 chinese tariff u.s import 10 give company breathe room reset inventory supply chain"
  },
  {
    "headline": "rvty q1 earning call resilient performance amid academic tariff headwind software diagnostic shine",
    "text": "life sciences company revvity nyse rvty report q1 cy2025 result beat wall street revenue expectation sale 2.3 year year $ 664.8 million company full year revenue guidance $ 2.85 billion midpoint come 0.6 analyst estimate non gaap profit $ 1.01 per 6.4 analyst consensus estimate"
  },
  {
    "headline": "3 p 500 doghouse",
    "text": "p 500 gspc home big well know company make go seek stability large cap create equal struggle slow growth decline margin increase competition"
  },
  {
    "headline": "1 safe steady exciting potential 2 avoid",
    "text": "low volatility may offer stability often come cost slow growth upside potential dynamic company"
  },
  {
    "headline": "revvity present upcoming conference",
    "text": "waltham mass april 30 2025 -revvity inc nyse rvty today announce present following conference"
  },
  {
    "headline": "mettler toledo mtd q1 earning expect",
    "text": "precision measurement company mettler toledo nyse mtd announce earning result tomorrow hour know"
  },
  {
    "headline": "revvity first quarter 2025 earning ep beat expectation",
    "text": "revvity nyse rvty first quarter 2025 result key result revenue us$664.8 2.3 1q 2024 net"
  },
  {
    "headline": "company news apr 29 2025",
    "text": "company news dpz rvty opra inmd"
  },
  {
    "headline": "revvity inc rvty q1 2025 earning call highlight surpass expectation strong",
    "text": "revvity inc rvty report robust q1 2025 performance exceed eps expectation demonstrate resilience amidst macroeconomic challenge"
  },
  {
    "headline": "q1 2025 revvity inc earning call",
    "text": "q1 2025 revvity inc earning call"
  },
  {
    "headline": "rvty rise q1 earning sale beat estimate 25 sale view",
    "text": "revvity first quarter result showcase strong growth diagnostic business along recovery life science segmental sale"
  },
  {
    "headline": "biotech firm revvity report well expect earning",
    "text": "revvity report first quarter earning top analyst estimate"
  },
  {
    "headline": "revvity rvty q1 earning key metric compare wall street estimate",
    "text": "top- bottom line number revvity rvty give sense business perform quarter end march 2025 could worth look key metric compare wall street estimate year ago value"
  },
  {
    "headline": "revvity join peer thermo fisher danaher tariff warning maintain profit outlook",
    "text": "reuter -medical equipment maker revvity monday join large peer warn impact tariff impose u.s president donald trump administration maintain annual profit outlook revvity anticipate $ 135 million impact tariff china however plan cost save measure expect benefit weak dollar due generate half revenue outside u.s warning come revvity post first quarter result wall street estimate steady demand tool use medical research"
  },
  {
    "headline": "revvity rvty beat q1 earning revenue estimate",
    "text": "revvity rvty deliver earning revenue surprise 5.21 0.39 respectively quarter end march 2025 number hold clue lie ahead"
  },
  {
    "headline": "revvity q1 earning snapshot",
    "text": "waltham mass ap revvity inc rvty monday report first quarter earning $ 42.2 million"
  },
  {
    "headline": "revvity nyse rvty post well expect sale q1 full year outlook slightly exceed expectation",
    "text": "life sciences company revvity nyse rvty announce well expect revenue q1 cy2025 sale 2.3 year year $ 664.8 million company full year revenue guidance $ 2.85 billion midpoint come 0.6 analyst estimate non gaap profit $ 1.01 per 6.4 analyst consensus estimate"
  },
  {
    "headline": "revvity announce result first quarter 2025",
    "text": "waltham mass april 28 2025 -revvity inc nyse rvty today report result first quarter end march 30 2025"
  },
  {
    "headline": "revvity rvty q1 earning report preview look",
    "text": "life sciences company revvity nyse rvty report result tomorrow hour know"
  },
  {
    "headline": "shareholder pleased quality revvity nyse rvty earning",
    "text": "revvity inc nyse rvty report healthy earning move much probably"
  },
  {
    "headline": "repligen bruker agilent medpace revvity skyrocket need know",
    "text": "number jump afternoon session major pop nasdaq 3.4 p 500 2.5 response positive outcome u.s.-china trade negotiation side agree pause tariff 90 day signal potential turning point ongoing tension rollback cut u.s tariff chinese good 30 chinese tariff u.s import 10 give company breathe room reset inventory supply chain"
  },
  {
    "headline": "rvty q1 earning call resilient performance amid academic tariff headwind software diagnostic shine",
    "text": "life sciences company revvity nyse rvty report q1 cy2025 result beat wall street revenue expectation sale 2.3 year year $ 664.8 million company full year revenue guidance $ 2.85 billion midpoint come 0.6 analyst estimate non gaap profit $ 1.01 per 6.4 analyst consensus estimate"
  },
  {
    "headline": "3 p 500 doghouse",
    "text": "p 500 gspc home big well know company make go seek stability large cap create equal struggle slow growth decline margin increase competition"
  },
  {
    "headline": "1 safe steady exciting potential 2 avoid",
    "text": "low volatility may offer stability often come cost slow growth upside potential dynamic company"
  },
  {
    "headline": "revvity present upcoming conference",
    "text": "waltham mass april 30 2025 -revvity inc nyse rvty today announce present following conference"
  },
  {
    "headline": "mettler toledo mtd q1 earning expect",
    "text": "precision measurement company mettler toledo nyse mtd announce earning result tomorrow hour know"
  },
  {
    "headline": "revvity first quarter 2025 earning ep beat expectation",
    "text": "revvity nyse rvty first quarter 2025 result key result revenue us$664.8 2.3 1q 2024 net"
  },
  {
    "headline": "company news apr 29 2025",
    "text": "company news dpz rvty opra inmd"
  },
  {
    "headline": "revvity inc rvty q1 2025 earning call highlight surpass expectation strong",
    "text": "revvity inc rvty report robust q1 2025 performance exceed eps expectation demonstrate resilience amidst macroeconomic challenge"
  },
  {
    "headline": "q1 2025 revvity inc earning call",
    "text": "q1 2025 revvity inc earning call"
  },
  {
    "headline": "rvty rise q1 earning sale beat estimate 25 sale view",
    "text": "revvity first quarter result showcase strong growth diagnostic business along recovery life science segmental sale"
  },
  {
    "headline": "biotech firm revvity report well expect earning",
    "text": "revvity report first quarter earning top analyst estimate"
  },
  {
    "headline": "revvity rvty q1 earning key metric compare wall street estimate",
    "text": "top- bottom line number revvity rvty give sense business perform quarter end march 2025 could worth look key metric compare wall street estimate year ago value"
  },
  {
    "headline": "revvity join peer thermo fisher danaher tariff warning maintain profit outlook",
    "text": "reuter -medical equipment maker revvity monday join large peer warn impact tariff impose u.s president donald trump administration maintain annual profit outlook revvity anticipate $ 135 million impact tariff china however plan cost save measure expect benefit weak dollar due generate half revenue outside u.s warning come revvity post first quarter result wall street estimate steady demand tool use medical research"
  },
  {
    "headline": "revvity rvty beat q1 earning revenue estimate",
    "text": "revvity rvty deliver earning revenue surprise 5.21 0.39 respectively quarter end march 2025 number hold clue lie ahead"
  },
  {
    "headline": "revvity q1 earning snapshot",
    "text": "waltham mass ap revvity inc rvty monday report first quarter earning $ 42.2 million"
  },
  {
    "headline": "revvity nyse rvty post well expect sale q1 full year outlook slightly exceed expectation",
    "text": "life sciences company revvity nyse rvty announce well expect revenue q1 cy2025 sale 2.3 year year $ 664.8 million company full year revenue guidance $ 2.85 billion midpoint come 0.6 analyst estimate non gaap profit $ 1.01 per 6.4 analyst consensus estimate"
  },
  {
    "headline": "revvity announce result first quarter 2025",
    "text": "waltham mass april 28 2025 -revvity inc nyse rvty today report result first quarter end march 30 2025"
  },
  {
    "headline": "revvity rvty q1 earning report preview look",
    "text": "life sciences company revvity nyse rvty report result tomorrow hour know"
  },
  {
    "headline": "revvity rvty could beat earning estimate",
    "text": "revvity rvty impressive earning surprise history currently possess right combination two key ingredient likely beat next quarterly report"
  },
  {
    "headline": "segmental performance drive rvty q1 earning beat likely",
    "text": "rvty first quarter result likely reflect decent performance diagnostic segment life science segment likely face continue challenge china"
  },
  {
    "headline": "revvity board declare quarterly dividend",
    "text": "waltham mass april 24 2025 -the board director revvity nyse rvty today declare regular quarterly dividend $ 0.07 per common dividend payable august 8 2025 shareholder record close business july 18 2025"
  },
  {
    "headline": "analyst estimate bausch lomb blco report decline earning look",
    "text": "bausch lomb blco possess right combination two key ingredient likely earning beat upcoming report get prepare key expectation"
  },
  {
    "headline": "3 cash produce skate thin ice",
    "text": "company generate cash automatically winner business stockpile cash fail reinvest wisely limit ability expand"
  },
  {
    "headline": "earning preview revvity rvty q1 earning expect decline",
    "text": "revvity rvty possess right combination two key ingredient likely earning beat upcoming report get prepare key expectation"
  },
  {
    "headline": "revvity inc nyse rvty",
    "text": "revvity inc nyse rvty see significant movement recent month nyse rise high"
  },
  {
    "headline": "revvity hold earning call monday april 28 2025",
    "text": "waltham mass april 03 2025 -revvity inc nyse rvty today announce release first quarter 2025 result prior open monday april 28 2025 company host conference call day 8 00 a.m. et discuss result prahlad singh president chief executive officer max krakowiak chief officer host conference call"
  },
  {
    "headline": "fda approve revvity auto pure platform tuberculosis test combo",
    "text": "world health organization recognise test enzyme link immunospot base interferon gamma release assay"
  },
  {
    "headline": "revvity secure fda approval improved automate latent tuberculosis test",
    "text": "waltham mass april 02 2025 -revvity inc nyse rvty today announce u.s food drug administration fda approve auto pure 2400 liquid handling platform spot .tb test initially launch outside u.s 2024 powerful combination allow laboratory improve productivity maintain superior clinical performance latent tuberculosis tb detection milestone mark significant advancement fight tb fast high-"
  },
  {
    "headline": "retain revvity",
    "text": "rvty strong product raise optimism"
  },
  {
    "headline": "1 healthcare target week 2 turn",
    "text": "personal health wellness one many secular tailwind healthcare company despite rosy long term prospect short term headwind covid inventory destocking harm industry return past six month healthcare collectively shed 11.1 drop bad p 500 4 decline"
  },
  {
    "headline": "total return revvity nyse rvty rise fast earning growth last five year",
    "text": "buy hold many year hope make profit probably want"
  },
  {
    "headline": "revvity tumble despite expand genomics england alliance",
    "text": "rvty expand alliance genomics england boost newborn genomic sequence research aim enhance early diagnosis healthcare outcome"
  },
  {
    "headline": "revvity expand alliance genomics england drive research newborn genomic sequence england",
    "text": "waltham mass march 20 2025 -revvity announce agreement genomics england far collaborate generation study provide sequence service"
  }
]